Track Elanco Animal Health Incorporat — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Elanco Animal Health Incorporat ELAN · Stock Open Elanco Animal Health Incorporat in new tab

26.78 USD
P/E
377.14
EPS
-0.30
P/B
2.02
ROE
-2.20
Beta
1.72
Target Price
30.85 USD
Loading chart...
Key Metrics
Earnings dateFeb. 23, 2027
P/E377.14
EPS-0.30
Book Value13.26
Price to Book2.02
Debt/Equity60.59
% Insiders1.206%
Growth
Revenue Growth0.11%
Earnings Growth4.41%
Estimates
Forward P/E20.77
Forward EPS1.29
Target Mean Price30.85

DCF valuation

Model fair value for Elanco Animal Health Incorporat (ELAN)
Result
Sign in to run the valuation for ELAN.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
13 analysts · consensus Buy · mean target 30.85 USD (low 25.00, high 35.00) · as of 10 Nov 2026
Low 25.00
Mean 30.85
High 35.00
Price 26.78
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Elanco Animal Health Incorporat Logo Elanco Animal Health Incorporat Analysis (ELAN)

United States Health Care Official Website Stock

Is Elanco Animal Health Incorporat a good investment? Elanco Animal Health Incorporat (ELAN) is currently trading at 26.78 USD. Market analysts have a consensus price target of 30.85 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 377.14. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Elanco Animal Health Incorporat is expected to release its next earnings report on Feb. 23, 2027. The market consensus estimate for Forward EPS is 1.29.

Investor FAQ

Does Elanco Animal Health Incorporat pay a dividend?

No, it does not currently pay a dividend.

What asset class is Elanco Animal Health Incorporat?

Elanco Animal Health Incorporat is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Feb. 23, 2027. The company currently has a trailing EPS of -0.30.

Company Profile

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio Family, Interceptor Plus, Drontal family, and Drontal Plus; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. It also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry. In addition, the company offers medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry. Further, it offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and Tru Family trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax tradmarks. The company sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Indianapolis, Indiana.

Exchange Ticker
FRA (Germany) 5EA.F
NYQ (United States) ELAN
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion